Skip to content

Clinical study on the effect of percutaneous acupoint electrical stimulation combined with ondansetron and dexamethasone on postoperative nausea and vomiting in patients with weight lossc

Clinical study on the effect of percutaneous acupoint electrical stimulation combined with ondansetron and dexamethasone on postoperative nausea and vomiting in patients with weight loss

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500096514
Enrollment
Unknown
Registered
2025-01-24
Start date
2025-02-01
Completion date
Unknown
Last updated
2025-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Weight loss

Interventions

control group:Percutaneous acupoint electrical stimulation to implement false stimulation 3h after surgery, once a day, 30 minutes each time (2 times in 2 days)
Experimental group A:Percutaneous acupoint electrical stimulation to implement true stimulation 3h after surgery, once a day, 30 minutes each time (twice in two days)
Experimental group B:Percutaneous acupoint electrical stimulation at 3h after surgery: true stimulation, once every 12h, for 2 days (3 times in total)
Experimental group C:Percutaneous acupoint electrical stimulation at 3h after surgery: true stimulation, once every 8h, for 2 days (4 times in total)

Sponsors

The First Affiliated Hospital of Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
16 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Age >16 years ; 2. Patients who are willing to undergo weight loss surgery and voluntarily sign informed consent; 3. Patients with moderate and high risk PONV risk score; 4. ASA grades II to IV.

Exclusion criteria

Exclusion criteria: 1. Patients who died during the study period; 2. Patients who refuse to participate and do not agree to sign informed consent; 3. Patients with severe mental illness or brain disease injury can not normally complete this survey.

Design outcomes

Primary

MeasureTime frame
The score of RINVR;

Secondary

MeasureTime frame
PONV risk factor score;The score of EQ-5D-5L;The score of HADS Hospital Anxiety and Depression Scale ;The number of rescues of antiemetic drugs;postoperative complications;

Countries

China

Contacts

Public ContactTang Kailin

Department of Gastrointestinal Surgery, the First Affiliated Hospital of Chongqing Medical Universityyanqing

tangkailin_0928@163.com+86 136 3797 0660

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026